|
New Delhi, Jan 02: An expert panel of India’s Central Drug Authority has recommended granting permission for restricted emergency use of Oxford-AstraZeneca vaccine Covishield, being manufactured by the Serum Institute of India, paving the way for the roll-out of the first Covid-19 shot in the country in the next few days.
Representational Image
All states and Union Territories, meanwhile, have begun conducting a dry run for Covid-19 vaccination to test the linkages between planning and implementation. The activity is proposed to be conducted in all state capitals in at least 3 session sites.
Bengal all set for COVID-19 vaccine dry run
Stage 3 clinical trials involve tens of thousands of…
